HealthQuill Clinical Remission
Bristol Myers Squibb’s final stage clinical trials for its Zeposia oral drug, to treat moderate to severe Crohn’s disease in adults, have failed to meet the goal of clinical remission.
Drugs Health Pharma

Bristol’s oral drug to treat Crohn’s disease fails remission test

HQ Team March 29, 2024: Bristol Myers Squibb’s final stage clinical trials for its Zeposia oral drug, to treat moderate to severe Crohn’s.

Read More